These discrepancies might be explained, in part, by the varied MHC class II level of MDSCs that has been described in different tumor models and human studies, and under some experimental conditions, MDSCs could inhibit the proliferation of T cells without affecting the IFN-γ production and vice versa (3, 4). Here, IFNG is linked to neoplasm.